263 related articles for article (PubMed ID: 31278971)
1. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets.
Shahid A; Bharadwaj M
Immunol Lett; 2019 Sep; 213():9-20. PubMed ID: 31278971
[TBL] [Abstract][Full Text] [Related]
2. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
3. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
4. Immunology of cancer stem cells in solid tumours. A review.
Maccalli C; Volontè A; Cimminiello C; Parmiani G
Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
[TBL] [Abstract][Full Text] [Related]
5. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
[TBL] [Abstract][Full Text] [Related]
6. The role of T helper 17 and regulatory T cells in tumor microenvironment.
Najafi S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
8. Influence of Innate Immunity on Cancer Cell Stemness.
Pastò A; Consonni FM; Sica A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
12. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
13. Macrophages and cancer stem cells: a malevolent alliance.
Allavena P; Digifico E; Belgiovine C
Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells, cytokine networks, and the tumor microenvironment.
Korkaya H; Liu S; Wicha MS
J Clin Invest; 2011 Oct; 121(10):3804-9. PubMed ID: 21965337
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Song Y; Yang JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
[TBL] [Abstract][Full Text] [Related]
17. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
[TBL] [Abstract][Full Text] [Related]
19. The paradox of Th17 cell functions in tumor immunity.
Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
